Akero Therapeutics, Inc. (AKRO)

Akero Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	185.92	340.24	234.21	249.77	150.48	187.24
Short-Term Investments	500.37	402.84	315.8	101.68	37.78	81.15
Cash & Short-Term Investments	686.29	743.08	550.01	351.45	188.26	268.39
Cash Growth	-24.05%	35.10%	56.50%	86.69%	-29.86%	96.77%
Prepaid Expenses	26.86	27.3	9.95	3.72	5.32	2.96
Total Current Assets	713.15	770.38	559.96	355.17	193.58	271.35
Property, Plant & Equipment	0.69	0.76	1.03	1.29	1.55	1.79
Long-Term Investments	442	54.75	19.28	-	-	-
Other Long-Term Assets	-	-	-	0.11	0.42	0.2
Total Assets	1,156	825.89	580.27	356.57	195.55	273.34
Accounts Payable	10.83	9.03	7.04	7.97	6.71	3.43
Accrued Expenses	24.3	30.1	11.57	10.79	18.22	9.39
Current Portion of Leases	0.3	0.29	0.52	0.33	0.21	0.29
Other Current Liabilities	0.35	0.34	-	-	-	-
Total Current Liabilities	42.44	39.75	19.13	19.08	25.13	13.11
Long-Term Debt	28.81	35.3	24.96	9.54	-	-
Long-Term Leases	0.45	0.53	0.82	1.08	1.31	1.52
Other Long-Term Liabilities	0.3	0.19	0.05	0.31	-	-
Total Liabilities	72	75.77	44.97	30.01	26.44	14.63
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	1,980	1,575	1,109	748.86	479.44	468.24
Retained Earnings	-896.88	-826.16	-574.1	-422.34	-310.3	-209.53
Comprehensive Income & Other	1.09	0.95	0.27	0.04	-0.03	-0
Total Common Equity	1,084	750.11	535.31	326.56	169.11	258.71
Shareholders' Equity	1,084	750.11	535.31	326.56	169.11	258.71
Total Liabilities & Equity	1,156	825.89	580.27	356.57	195.55	273.34
Total Debt	36.23	36.12	26.31	10.95	1.52	1.81
Net Cash (Debt)	1,092	761.71	542.99	340.5	186.74	266.58
Net Cash Growth	25.84%	40.28%	59.47%	82.34%	-29.95%	95.56%
Net Cash Per Share	15.17	11.35	10.33	8.73	5.36	8.47
Filing Date Shares Outstanding	79.72	79.62	56.3	46.97	35.01	34.77
Total Common Shares Outstanding	79.67	72.38	55.75	46.87	34.9	34.74
Working Capital	670.71	730.63	540.83	336.09	168.45	258.23
Book Value Per Share	13.60	10.36	9.60	6.97	4.85	7.45
Tangible Book Value	1,084	750.11	535.31	326.56	169.11	258.71
Tangible Book Value Per Share	13.60	10.36	9.60	6.97	4.85	7.45

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q